South Korea’s Ministry of Food and Drug Safety (MFDS) recently ordered Medicube and Dr.G to stop advertising after finding misleading marketing claims.
Medicube and Dr. G had their product ads suspended for violating the Cosmetics Act. The main reason for the ban was that the marketing was mislead, transitioning cosmetics into medicines.
The products hit with the ban are;
- Medicube One Day Exosome Pore Ampoule 2000
- Medicube One Day Exosome Shot Pore Ampoule 7500
- Dr.G Vita Clear Sun Serum
According to the Korea Food and Drug Administration (KFDA) on November 11, Dr. G of Fine World Cosmetics was suspended from advertising until June 5 for ‘Vita Clear Sun Serum’ products.
Medicube will also be suspended until June 8 for One Day Exosome Pore Ampoule 2000 and One Day Exosome Shot Pore Ampoule 7500.
Regulators claimed that some marketing was misleading by suggesting the products;
- regenerate skin
- repair cells &
- dramatically shrink pores
According to South Korea’s Ministry of Food and Drug Safety (MFDS) cosmetics can’t make medical, therapeutic or drug-like claims.
The advertising suspension doesn’t mean the products aer unsafe, it just requires the Medicube and Dr.G to adjust their marketing to follow cosmetic regulations.
With many K-beauty brands promoting ingredients like exosomes as advanced scientific biotech skincare.
Regulators are now paying closer attention to product advertising and monitoring how brands market their products to ensure they don’t;
- claim exaggerated scientific evidence
- misrepresent ingredients or
- confuse consumers
Regulators want less hype and clearer skincare claims, so that consumers aren’t misled. This means;
- clearer cosmetic claims
- better consumer protection
- less misleading “medical style” skincare marketing
Source: Seoul: News 1 Shin Min-kyung